{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T13:10:10Z","timestamp":1781788210598,"version":"3.54.5"},"reference-count":79,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Resveratrol, a polyphenolic compound commonly found in natural plants and fruits, exhibits potential in preventing optic nerve damage in glaucoma, as indicated by several animal studies. However, there is presently a dearth of relevant evidence available for comprehensive summarization.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this study, we conducted an extensive search across 7 electronic databases, encompassing all pertinent animal studies for a systematic review and meta-analysis. Methodological quality was evaluated using SYRCLE\u2019s bias risk tool, with statistical analysis performed using Stata 17.0. The primary outcome measures included the survival of retinal ganglion cells and retinal thickness.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The comprehensive analysis of the 30 included studies revealed that resveratrol can enhance the expression of Sirtuin 1(SIRT1) protein in retinal tissue (SMD: 3.00, 95% CI: 2.46, 3.53, P = 0.095), boost the survival rate of retinal ganglion cells (SMD: 4.33, 95% CI: 3.28, 5.38, P &amp;lt; 0.05), decelerate the thinning of retinal thickness (SMD: 4.26, 95% CI: 2.77, 5.75, P &amp;lt; 0.05), and enhance visual function. Its potential mechanism of action may involve the suppression of pro-inflammatory cytokine levels and cell apoptosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Resveratrol emerges as a promising agent for mitigating glaucoma-related retinal damage. However, given that the animal research models utilized in the study may not fully reflect the intricate scenarios of multiple coexisting diseases in clinical settings, and the administration methods in animal models may differ from those in clinical practice, future studies should aim to provide higher levels of evidence to facilitate the clinical translation of these findings.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic Review Registration:<\/jats:title><jats:p>identifier [CRD42024535673].<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2024.1521188","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T06:13:27Z","timestamp":1736921607000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Protective effect of resveratrol on retinal damage in glaucoma: a systematic review and meta-analysis of preclinical studies"],"prefix":"10.3389","volume":"15","author":[{"given":"Feng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junli","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenmei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"key":"B1","article-title":"Protective effect of the SIRT1 activator resveratrol on experimental glaucomatous retinas","year":"2016"},{"key":"B2","doi-asserted-by":"publisher","first-page":"391","DOI":"10.4103\/1673-5374.245465","article-title":"Neuroinflammation as a target for glaucoma therapy","volume":"14","author":"Adornetto","year":"2019","journal-title":"Neural Regen. Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1097\/IJG.0000000000001728","article-title":"Changes in prices and eye-care providers prescribing patterns of glaucoma medications in the United States between 2013 and 2019","volume":"30","author":"Barayev","year":"2021","journal-title":"J. Glaucoma"},{"key":"B4","doi-asserted-by":"publisher","first-page":"100916","DOI":"10.1016\/j.preteyeres.2020.100916","article-title":"Inflammation in Glaucoma: from the back to the front of the eye, and beyond","volume":"83","author":"Baudouin","year":"2021","journal-title":"Prog. Retin Eye Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1136\/bjophthalmol-2017-311258","article-title":"Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections","volume":"102","author":"Bourne","year":"2018","journal-title":"Br. J. Ophthalmol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"387","DOI":"10.4137\/bmi.s692","article-title":"Effects of cyclooxygenase inhibitors on apoptotic neuroretinal cells","volume":"3","author":"Brust","year":"2008","journal-title":"Biomark. Insights"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.3390\/nu14142974","article-title":"The role of resveratrol in eye diseases-A review of the literature","volume":"14","author":"Bryl","year":"2022","journal-title":"Nutrients"},{"key":"B8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1167\/iovs.61.3.13","article-title":"Protection of the retinal ganglion cells: intravitreal injection of resveratrol in mouse model of ocular hypertension","volume":"61","author":"Cao","year":"2020","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"321","DOI":"10.13481\/j.1671-587x.20180221","article-title":"Effects of resveratrol on expressions of Caspase-3 and Bcl-2 in retina tissue of rats with retinal ischemia-reperfusion injury","volume":"44","author":"Chang","year":"2018","journal-title":"J. Jilin Univ. Med. Ed."},{"key":"B10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13024-020-00372-w","article-title":"NLRP12 collaborates with NLRP3 and NLRC4 to promote pyroptosis inducing ganglion cell death of acute glaucoma","volume":"15","author":"Chen","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"B11","volume-title":"Protective effects of resveratrol on retinal ischemia-reperfusion injury in rats","author":"Chen","year":"2018"},{"key":"B12","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1007\/s10495-013-0837-3","article-title":"Dynamic mobilization of PGC-1\u03b1 mediates mitochondrial biogenesis for the protection of RGC-5 cells by resveratrol during serum deprivation","volume":"18","author":"Chen","year":"2013","journal-title":"Apoptosis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1016\/j.ymthe.2023.03.008","article-title":"Neuroserpin gene therapy inhibits retinal ganglion cell apoptosis and promotes functional preservation in glaucoma","volume":"31","author":"Chitranshi","year":"2023","journal-title":"Mol. Ther."},{"key":"B14","doi-asserted-by":"publisher","first-page":"853","DOI":"10.3390\/antiox12040853","article-title":"Effects of resveratrol on vascular function in retinal ischemia-reperfusion injury","volume":"12","author":"Chronopoulos","year":"2023","journal-title":"ANTIOXIDANTS"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.3390\/biom11081239","article-title":"Targeting the NLRP3 inflammasome in glaucoma","volume":"11","author":"Coyle","year":"2021","journal-title":"Biomolecules"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.3390\/ijms22031295","article-title":"New Highlights of resveratrol: a review of properties against ocular diseases","volume":"22","author":"Delmas","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B17","first-page":"36","article-title":"Role of the PGE2 receptor in ischemia-reperfusion injury of the rat retina","volume":"26","author":"Deng","year":"2020","journal-title":"Mol. Vis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"8454","DOI":"10.1007\/s12035-024-04105-8","article-title":"Resveratrol ameliorates retinal ischemia-reperfusion injury by modulating the NLRP3 inflammasome and keap1\/Nrf2\/HO-1 signaling pathway","volume":"61","author":"Feng","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1354569","DOI":"10.3389\/fncel.2024.1354569","article-title":"Glaucoma: from pathogenic mechanisms to retinal glial cell response to damage","volume":"18","author":"Fernandez-Albarral","year":"2024","journal-title":"Front. Cell Neurosci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/s1350-9462(02)00008-3","article-title":"The impact of ocular blood flow in glaucoma","volume":"21","author":"Flammer","year":"2002","journal-title":"Prog. Retin Eye Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/s0042-6989(01)00194-8","article-title":"Prospects for relevant glaucoma models with retinal ganglion cell damage in the rodent eye","volume":"42","author":"Goldblum","year":"2002","journal-title":"Vis. Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.14009\/j.issn.1672-2124.2020.11.011","article-title":"Protective effect of resveratrol on optic nerve and its effect on the expression of Bcl-2, Bax and caspase-9 in rats with chronic glaucoma","volume":"20","author":"Guowu","year":"2020","journal-title":"China Hosp. Pharm. Eval. Analysis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3980\/j.issn.1672-5123.2021.1.05","article-title":"Protective effect and mechanism of resveratrol on optic nerve injury in glaucoma rats","volume":"21","author":"He","year":"2021","journal-title":"Int. J. Ophthalmol-Chi"},{"key":"B24","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2288-14-43","article-title":"SYRCLE's risk of bias tool for animal studies","volume":"14","author":"Hooijmans","year":"2014","journal-title":"Bmc Med. Res. Methodol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/s12974-021-02366-x","article-title":"Interplay between Muller cells and microglia aggravates retinal inflammatory response in experimental glaucoma","volume":"18","author":"Hu","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"B26","volume-title":"Changes in the expression of Sirtuins in the retina and optic nerve before and after acute retinal ischemia in rats, and the regulation of mitochondrial dynamics by resveratrol-mediated SIRT1 activation","author":"Ji","year":"2016"},{"key":"B27","volume-title":"Protective effects and mechanisms of resveratrol on retinal ganglion cells in murine retinal ischemic injury","author":"Ji","year":"2022"},{"key":"B28","doi-asserted-by":"publisher","first-page":"137712","DOI":"10.1016\/j.neulet.2024.137712","article-title":"Ameliorative effect of resveratrol on acute ocular hypertension induced retinal injury through the SIRT1\/NF-\u03baB pathway","volume":"826","author":"Ji","year":"2024","journal-title":"Neurosci. Lett."},{"key":"B29","first-page":"2697","article-title":"Apoptotic retinal neuronal death by ischemia-reperfusion is executed by two distinct caspase family proteases","volume":"40","author":"Katai","year":"1999","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1750-1326-8-21","article-title":"Progressive morphological changes and impaired retinal function associated with temporal regulation of gene expression after retinal ischemia\/reperfusion injury in mice","volume":"8","author":"Kim","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"B31","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3390\/molecules21030304","article-title":"Anti-oxidant, anti-inflammatory and anti-angiogenic properties of resveratrol in ocular diseases","volume":"21","author":"Lancon","year":"2016","journal-title":"Molecules"},{"key":"B32","volume-title":"The role of endoplasmic reticulum stress in retinal ischemia-reperfusion injury","author":"Li","year":"2012"},{"key":"B33","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.exer.2018.06.014","article-title":"Rapamycin mediates mTOR signaling in reactive astrocytes and reduces retinal ganglion cell loss","volume":"176","author":"Li","year":"2018","journal-title":"Exp. Eye Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1371\/journal.pgen.0010004","article-title":"Susceptibility to neurodegeneration in a glaucoma is modified by Bax gene dosage","volume":"1","author":"Libby","year":"2005","journal-title":"Plos Genet."},{"key":"B35","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/s0969-9961(03)00010-x","article-title":"Activation of epidermal growth factor receptor signals induction of nitric oxide synthase-2 in human optic nerve head astrocytes in glaucomatous optic neuropathy","volume":"13","author":"Liu","year":"2003","journal-title":"Neurobiol. Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.survophthal.2022.09.001","article-title":"Co-occurrence of chronic kidney disease and glaucoma: epidemiology and etiological mechanisms","volume":"68","author":"Liu","year":"2023","journal-title":"Surv. Ophthalmol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1167\/iovs.18-26216","article-title":"Neuroprotective effects of HSF1 in retinal ischemia-reperfusion injury","volume":"60","author":"Liu","year":"2019","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"B38","volume-title":"Neuroprotective effects and mechanisms of resveratrol on retinal ischemia-reperfusion injury in rats","author":"Liu","year":"2013"},{"key":"B39","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.fct.2008.10.029","article-title":"Resveratrol prevents the expression of glaucoma markers induced by chronic oxidative stress in trabecular meshwork cells","volume":"47","author":"Luna","year":"2009","journal-title":"Food Chem. Toxicol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1167\/iovs.18-23806","article-title":"Resveratrol delays retinal ganglion cell loss and attenuates gliosis-related inflammation from ischemia-reperfusion injury","volume":"59","author":"Luo","year":"2018","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"B41","volume-title":"Study on the role and mechanism of resveratrol and SIRT1 in retinal ischemia-reperfusion injury in mice","author":"Luo","year":"2020"},{"key":"B42","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00417-019-04580-z","article-title":"SIRT1 is required for the neuroprotection of resveratrol on retinal ganglion cells after retinal ischemia-reperfusion injury in mice","volume":"258","author":"Luo","year":"2020","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2017.01.002","article-title":"BAX to basics: how the BCL2 gene family controls the death of retinal ganglion cells","volume":"57","author":"Maes","year":"2017","journal-title":"Prog. Retin Eye Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"3860","DOI":"10.1167\/iovs.08-3267","article-title":"Brn3a as a marker of retinal ganglion cells: qualitative and quantitative time course studies in naive and optic nerve-injured retinas","volume":"50","author":"Nadal-Nicolas","year":"2009","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.brainresbull.2003.07.005","article-title":"Pharmacologic neuroprotection with an inhibitor of nitric oxide synthase for the treatment of glaucoma","volume":"62","author":"Neufeld","year":"2004","journal-title":"Brain Res. Bull."},{"key":"B46","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1167\/tvst.13.8.37","article-title":"Comparison of SNCG and NEFH promoter-driven expression of human SIRT1 expression in a mouse model of glaucoma","volume":"13","author":"O'Neill","year":"2024","journal-title":"Transl. Vis. Sci. Technol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"70","DOI":"10.2174\/156720209787466019","article-title":"Resveratrol and neurodegenerative diseases: activation of SIRT1 as the potential pathway towards neuroprotection","volume":"6","author":"Pallas","year":"2009","journal-title":"Curr. Neurovasc Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.3892\/ijmm.2020.4711","article-title":"Resveratrol protects retinal ganglion cells against ischemia induced damage by increasing Opa1 expression","volume":"46","author":"Pang","year":"2020","journal-title":"Int. J. Mol. Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/IJG.0000000000001730","article-title":"Economic and clinical burden associated with intensification of glaucoma topical therapy: a US claims-based analysis","volume":"30","author":"Patel","year":"2021","journal-title":"J. Glaucoma"},{"key":"B50","first-page":"1048","article-title":"Bcl-2, Bcl-xL, and p-AKT are involved in neuroprotective effects of transcription factor Brn3b in an ocular hypertension rat model of glaucoma","volume":"22","author":"Phatak","year":"2016","journal-title":"Mol. Vis."},{"key":"B51","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3109\/02713683.2015.1004719","article-title":"Riluzole- and resveratrol-induced delay of retinal ganglion cell death in an experimental model of glaucoma","volume":"41","author":"Pirhan","year":"2016","journal-title":"Curr. Eye Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.tips.2004.12.009","article-title":"The emerging therapeutic potential of sirtuin-interacting drugs: from cell death to lifespan extension","volume":"26","author":"Porcu","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"key":"B53","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1001\/jamaophthalmol.2015.5479","article-title":"Self-reported function, health resource use, and total health care costs among medicare beneficiaries with glaucoma","volume":"134","author":"Prager","year":"2016","journal-title":"Jama Ophthalmol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.5530\/pj.2023.15.219","article-title":"Intravitreal resveratrol as anti apoptotic agent against retinal ganglion cell loss in ischemic reperfusion injury","volume":"15","author":"Prasetya","year":"2023","journal-title":"Pharmacogn. J."},{"key":"B55","first-page":"774","article-title":"Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis","volume":"36","author":"Quigley","year":"1995","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1007\/s12035-021-02675-5","article-title":"Bax contributes to retinal ganglion cell dendritic degeneration during glaucoma","volume":"59","author":"Risner","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"394","DOI":"10.18240\/ijo.2022.03.04","article-title":"Resveratrol prevents hypoxia-induced retinal ganglion cell death related with ErbB2","volume":"15","author":"Seong","year":"2022","journal-title":"Int. J. Ophthalmol-Chi"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1080\/02713683.2017.1344713","article-title":"Resveratrol ameliorates retinal ischemia\/reperfusion injury in C57BL\/6J mice via downregulation of caspase-3","volume":"42","author":"Seong","year":"2017","journal-title":"Curr. Eye Res."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2022.115","article-title":"Resveratrol nanoparticles reduce retinal ganglion cell loss in glaucoma","volume":"100","author":"Shamsher","year":"2022","journal-title":"Acta Ophthalmol."},{"key":"B60","first-page":"2884","article-title":"Isoforms of nitric oxide synthase in the optic nerves of rat eyes with chronic moderately elevated intraocular pressure","volume":"40","author":"Shareef","year":"1999","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"B61","doi-asserted-by":"publisher","first-page":"3602","DOI":"10.1167\/iovs.07-0131","article-title":"SIRT1 activation confers neuroprotection in experimental optic neuritis","volume":"48","author":"Shindler","year":"2007","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"B62","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.3892\/etm.2018.6441","article-title":"Effect of ranibizumab on levels of IL-6 and VEGF in peripheral blood and aqueous humor of glaucoma rat model and association of IL-6 and VEGF with optic nerve damage","volume":"16","author":"Song","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"key":"B64","doi-asserted-by":"publisher","first-page":"e0137913","DOI":"10.1371\/journal.pone.0137913","article-title":"The cost-effectiveness analysis of teleglaucoma screening device","volume":"10","author":"Thomas","year":"2015","journal-title":"Plos One"},{"key":"B65","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.exer.2012.11.022","article-title":"Neuroprotective effect of resveratrol prophylaxis on experimental retinal ischemic injury","volume":"108","author":"Vin","year":"2013","journal-title":"Exp. Eye Res."},{"key":"B66","doi-asserted-by":"publisher","first-page":"108249","DOI":"10.1016\/j.exer.2020.108249","article-title":"Resveratrol protects retinal ganglion cell axons through regulation of the SIRT1-JNK pathway","volume":"200","author":"Wu","year":"2020","journal-title":"Exp. Eye Res."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.4314\/tjpr.v19i6.16","article-title":"Resveratrol protects the retina from I\/R injury by inhibiting RGCS apoptosis, glial activation and expression of inflammatory factors","volume":"19","author":"Xia","year":"2020","journal-title":"Trop. J. Pharm. Res."},{"key":"B68","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3892\/mmr.2024.13207","article-title":"Apoptosis in glaucoma: a new direction for the treatment of glaucoma (Review)","volume":"29","author":"Xia","year":"2024","journal-title":"Mol. Med. Rep."},{"key":"B69","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1167\/iovs.64.15.28","article-title":"Resveratrol alleviates retinal ischemia-reperfusion injury by inhibiting the NLRP3\/gasdermin D\/Caspase-1\/Interleukin-1\u03b2 pyroptosis pathway","volume":"64","author":"Xie","year":"2023","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"B70","doi-asserted-by":"publisher","first-page":"564","DOI":"10.3969\/j.issn.1004-2407.2021.04.010","article-title":"Protective effects of resveratrol on the retina of glaucomatous rats based on the SIRT1 pathway","volume":"36","author":"Xiong","year":"2021","journal-title":"Northwest Pharm. J."},{"key":"B71","first-page":"155","article-title":"The expression of Bcl-2, Bcl-xl, Bak and Bax proteins in axons of the optic nerve in closed-angle glaucoma","volume":"106","author":"Zalewska","year":"2004","journal-title":"Klin. Ocz."},{"key":"B72","doi-asserted-by":"publisher","first-page":"102687","DOI":"10.1016\/j.redox.2023.102687","article-title":"Pathologically high intraocular pressure induces mitochondrial dysfunction through Drp1 and leads to retinal ganglion cell PANoptosis in glaucoma","volume":"62","author":"Zeng","year":"2023","journal-title":"Redox Biol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.lfs.2018.06.010","article-title":"Resveratrol ameliorates disorders of mitochondrial biogenesis and dynamics in a rat chronic ocular hypertension model","volume":"207","author":"Zhang","year":"2018","journal-title":"Life Sci."},{"key":"B74","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1166\/jbt.2022.2874","article-title":"Therapeutic effects of sirtuin 1 activator on glaucoma mice and the regulation mechanism of mitogen-activated protein kinase pathway","volume":"12","author":"Zhao","year":"2022","journal-title":"J. Biomater. Tiss. Eng."},{"key":"B75","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.exer.2018.12.006","article-title":"Neuronal apoptosis, axon damage and synapse loss occur synchronously in acute ocular hypertension","volume":"180","author":"Zhou","year":"2019","journal-title":"Exp. Eye Res."},{"key":"B79","article-title":"Protective effect of the SIRT1 activator resveratrol on experimental glaucomatous retinas","volume-title":"The 13th Jiangxi Provincial Integrated Traditional Chinese and Western Medicine Ophthalmology Academic Exchange Conference and the 8th Academic Conference of the Ganzhou Medical Association Ophthalmology Society","author":"Zhou","year":"2001"},{"key":"B76","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3892\/ijmm.2018.3623","article-title":"Role of Sirtuin 1 in the pathogenesis of ocular disease (Review)","volume":"42","author":"Zhou","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"B77","article-title":"Neuro-protective effect of resveratrol on ischemia\/reperfusion-Induced Retinal Injury in mice","volume":"59","author":"Zhu","year":"2018","journal-title":"Investigative Ophthalmol. Vis. Sci."},{"key":"B78","doi-asserted-by":"publisher","first-page":"5097","DOI":"10.1167\/iovs.13-12157","article-title":"SIRT1 promotes RGC survival and delays loss of function following optic nerve crush","volume":"54","author":"Zuo","year":"2013","journal-title":"Invest Ophthalmol. Vis. Sci."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1521188\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T06:13:40Z","timestamp":1736921620000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1521188\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":79,"alternative-id":["10.3389\/fphar.2024.1521188"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1521188","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]},"article-number":"1521188"}}